Stay updated on FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays a new software revision label, updating from v3.6.2 to v3.6.3. This indicates a minor update to the site's underlying version rather than a change to the study data or user-facing content.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a recent minor update to the page's documentation or metadata. This does not alter substantive study details or user-facing content.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now indicates that enrollment has ended and adds new guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with a header update ('Intervention/Treatment') and a revision note (Revision: v3.6.0), reflecting navigation and informational updates.SummaryDifference0.5%

- Check39 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. This indicates a small version bump and does not modify substantive content.SummaryDifference0.1%

- Check60 days agoChange DetectedA new site revision tag (v3.5.4) was added and the previous tag (v3.5.3) was removed, indicating a minor update to the page template. The update reflects a version control change and does not modify the study content or data displayed.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page footer revision marker was updated from v3.5.0 to v3.5.3, reflecting a minor technical/version change without altering the displayed ClinicalTrials.gov study information.SummaryDifference0.1%

Stay in the know with updates to FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page.